| Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells CD Zahm, VT Colluru, DG McNeel Cancer immunology research 5 (8), 630-641, 2017 | 62 | 2017 |
| DNA vaccines for prostate cancer CD Zahm, VT Colluru, DG McNeel Pharmacology & therapeutics 174, 27-42, 2017 | 53 | 2017 |
| TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8+ T Cells CD Zahm, VT Colluru, SJ McIlwain, IM Ong, DG McNeel Cancer immunology research 6 (11), 1364-1374, 2018 | 48 | 2018 |
| Preclinical and clinical development of DNA vaccines for prostate cancer VT Colluru, LE Johnson, BM Olson, DG McNeel Urologic oncology: seminars and original investigations 34 (4), 193-204, 2016 | 48 | 2016 |
| B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines VT Colluru, DG McNeel Oncotarget 7 (42), 67901, 2016 | 31 | 2016 |
| Mini-intronic plasmid vaccination elicits tolerant LAG3+ CD8+ T cells and inferior antitumor responses VT Colluru, CD Zahm, DG McNeel Oncoimmunology 5 (10), e1223002, 2016 | 24 | 2016 |
| Vaccination with high-affinity epitopes impairs antitumor efficacy by increasing PD-1 expression on CD8+ T cells. Cancer Immunol. Res. 2017; 5: 630–641. doi: 10.1158/2326-6066 CD Zahm, VT Colluru, DG McNeel CIR-16-0374, 0 | 13 | |
| Safety and Immunological Efficacy of a DNA Vaccine Encoding the Androgen Receptor Ligand‐Binding Domain (AR‐LBD) BM Olson, ES Bradley, T Sawicki, W Zhong, EA Ranheim, JE Bloom, ... The Prostate 77 (7), 812-821, 2017 | 11 | 2017 |
| TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8 (+) T Cells. Cancer Immunol. Res. 2018; 6: 1364–1374. doi: 10.1158/2326-6066 CD Zahm, VT Colluru, SJ McIlwain, IM Ong, DG McNeel CIR-18-0243.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 6 | |
| In-silico characterization of ECE-1 inhibitors PA Babu, VTSS Colluru, N Anaparthy Computers in Biology and Medicine 42 (4), 446-457, 2012 | 5 | 2012 |
| Targeting dna vaccines to b cells as primary antigen presenting cells DG McNeel, VT Colluru US Patent App. 17/191,378, 2021 | 2 | 2021 |
| Targeting dna vaccines to b cells as primary antigen presenting cells DG McNeel, VT Colluru US Patent App. 14/935,095, 2016 | 2 | 2016 |
| Abstract CN04-03: DNA vaccines as treatment for prostate cancer-understanding mechanisms of resistance BT Rekoske, VT Colluru, DG McNeel Molecular Cancer Therapeutics 14 (12_Supplement_2), CN04-03-CN04-03, 2015 | 1 | 2015 |
| Immunization with minicircle and mini-intronic DNA vectors induce LAG-3 expressing CD8+ T cells and inferior anti-tumor responses VT Colluru, DG McNeel Cancer Research 75 (15_Supplement), 2502-2502, 2015 | 1 | 2015 |
| B lymphocyte mediated antigen presentation of plasmid DNA VT Colluru, DG McNeel Journal for ImmunoTherapy of Cancer 1 (Suppl 1), 2013 | 1 | 2013 |
| A Study on Refractive Errors of A Random Population Selected From Urban Areas of Visakhapatnam, India VTSS Colluru, N Anaparthy, KR Sripathi, VR Kumari | 1 | 2011 |
| Targeting dna vaccines to b cells as primary antigen presenting cells DG McNeel, VT Colluru US Patent App. 16/278,415, 2019 | | 2019 |
| PI3-Kinase Inhibition and LAG-3 Checkpoint blockade as a Combination Therapy for Cancer DG McNeel, VT Colluru, CD Zahm US Patent App. 15/674,066, 2018 | | 2018 |
| Mini-intronic plasmid DNA vaccines in combination with LAG3 blockade D McNeel, V Colluru US Patent 9,827,308, 2017 | | 2017 |
| GP350 containing exosomes as DNA vaccine carriers VT Colluru, DG McNeel Cancer Research 76 (14_Supplement), 2360-2360, 2016 | | 2016 |
